Robo-Advisor Emotomy Partners with Mercury Capital for Launch of AlphaOptimizer Platform
Today, B2B robo-advisor Emotomy and Mercury Capital Advisors, the globally recognized alternatives placement agent, announced that the Emotomy engine will power AlphaOptimizer as part of Mercury Capital’s suite of analytical tools offered on the iFunds Private Wealth Advisor platform.
Emotomy, a top online investment analytics, trade execution, risk management, and reporting platform for RIAs, brokerage houses and banks, is already providing customized portfolio management for more than 4,000 client accounts in the U.S. and Europe. The company has experienced more than 100% growth in the last 12 months.
AlphaOptimizer allows Mercury’s clients — registered investment advisors, endowments, family offices, foundations and other sophisticated investment entities — to monitor, manage, and analyze investment choices in the context of their portfolios, using Emotomy’s visually intuitive and tool-rich investment management engine.
Michael Ricciardi, Managing Partner of Mercury, said that making the AlphaOptimizer available to clients will allow them to see the empirical impact of adding specific alternative investment strategies to their investment portfolio in quantitative, user-friendly detail. Mercury is a seasoned team of finance professionals entrusted with representing hedge funds, private equity, real estate, venture capital, credit, distressed and infrastructure funds, and it has been engaged on more than 100 mandates representing in excess of $150 billion in capital commitments. Mercury launched AlphaOptimizer to facilitate quantifiable, comparative analyses of iFunds investment choices.
In contrast to many direct-to-consumer robo-advisors, Emotomy was created specifically for financial professionals who provide deep expertise and a “safe set of hands” overseeing client portfolios. According to Emotomy co-founder and CEO Patrick Beaudan, “Emotomy allows clients to analyze alternative investments that have traditionally been a ‘black box’ and will enhance transparency for investors. Emotomy offers tools previously only available to sophisticated financial institutions.”